LUCIUS 卢修斯 缴更昔洛韦 Valganciclovir视网膜炎 CMV感染
LUCIUS 卢修斯 缴更昔洛韦 Valganciclovir视网膜炎 CMV感染
缴更昔洛韦
美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品
Valganciclovir
老挝国家食药监局批准上市
老挝国家药检所检测认证
视网膜炎
Each film-coated tablet contains Valganciclovir HCT
LUCiUS
PHARMACEUTICALS
agancciovir ......... 450mg.
LuciValgan
CMV感染
ctomegalovirus (CMV)DNA polymerase inhibitor
Adult Patiente
. Treatment of CMV retinitis in patients with
acquired immunodeticiency syndrome (AIDS)
* Prevention of CMV disease in kidney, heart, an
kidney-pancreas transplant patients at high risk.
Valganciclovir Tablets
Pediatrie Daliante
. Prevention of CMV disease in kidney and hea
Rx Only
transplant patients at high risk
FDA批准
Dosage and Use:
See full prescribing information for LuciValgan.
450mg
see Tuit pressi
Storage: in a dry place and store at 20℃ 1o 25℃.
Warning:
Keep medicine out of reach of Children. Do not
administer Luci Valgan during Pregnancy and
PLEASE SEE PACKAGE INSERT
ns Preenancy and
Manufactured and Marketed by:
LUCIUS
权威认证
Thongmang village, Xaythany district,
Vientiane Capital, Laos
Warning: Tobe sold bv retatl on orescriotion
of regstered nhusicians onlu and at firootad
60 Tablets
口碑质量
适应症:
1、成人患者:
1艾滋病患者CMV视网膜炎的治疗;
2预防高危肾脏、心脏和肾胰腺移植患者的巨细胞病毒疾病。
2、儿科患者:高危肾脏和心脏移植患者CMV疾病的预防。
推荐剂量:
1、随餐服用;
2、具体剂量方案,请阅读说明书。
无法加载取货服务可用情况
99999 件存货
查看完整详细信息